Overview:
Animal models often fail to predict human outcomes, leading to costly trial failures and recalls. This white paper explores the shift toward advanced in vitro alternatives — such as 3D tissues, organoids, and organ-on-a-chip—that better replicate human biology. Learn how these models improve safety, efficacy, and regulatory compliance while reducing costs and eliminating ethical concerns.
Resource type: White Paper
Page Count: 8 pages
Read Time: 10 minutes
Key Takeaways:
- Animal models often fail to predict human outcomes, causing costly trial failures.
- Regulatory shifts encourage adoption of human-relevant in vitro methods.
- Advanced models like 3D tissues, organoids, and organ-on-a-chip improve accuracy.
- In vitro testing reduces costs, increases throughput, and eliminates ethical concerns.
- OECD-approved guidelines validate these alternatives for safety and efficacy testing.
